Dementia and Alzheimer Disease

Epilepsy

Headache and Migraine

Movement Disorders

Multiple Sclerosis

Neuromuscular

Sleep Disorders

Stroke

News

Media

All Videos

Medical World News

Podcasts

Weekly Recap

Cure Connections

Insights

News Network

NeurologyLive Peer Exchange

Conferences

Conference Coverage

Conference Listing

CME/CE

Partners

Publications

NeurologyLive

International Journal of MS Care

Resources

Disease Spotlight

Fellows' Corner

Future Leaders in Neurology

Giants of Multiple Sclerosis

Interactive Tools

Live Events

Neurology Resources

Virtual Events

Subscribe

eNewsletter

Print Subscription

Articles

Over a 12-week treatment period, patients with Parkinson disease on light therapy demonstrated statistically significant improvements of 58% and 40% in lower and upper limb coordination and movement. 

SYMBYX Neuro Light Therapy Wellness Helmet Positively Impacts Parkinson Disease Symptoms

As a recap from MDA 2023, get caught up on some of the latest news in neuromuscular diseases as the NeurologyLive® team shares some of our data updates.

Recapping Research From 2023 MDA

Neurology News Network for the week ending March 25, 2023. [WATCH TIME: 3 minutes]

Efgartigimod Effective Across Subgroups, FDA to Hold AdComm Meeting on SRP-9001, Reboxetine Demonstrates Positive Effect on Obstructive Sleep Apnea

Videos

At the 2023 MDA Conference, a neurology nurse practitioner in the Neuromuscular Division at Washington University in St. Louis talked about adverse event management of gene therapies in Duchenne muscular dystrophy. [WATCH TIME: 2 minutes]  

Clinical Trial Experiences Managing Adverse Events in Gene Therapy for DMD: Natalie L. Goedeker, CPNP

The neurologist and migraine expert from NYU Langone Health.

The neurologist and migraine expert from NYU Langone Health shared her reactions to the recently approved zavegepant nasal spray (Zavzpret; Pfizer) for the treatment of migraine. [WATCH TIME: 5 minutes]  

Newly Approved Migraine Nasal Spray Offers Alternative Treatment to Injections, Oral Medications: Shae Datta, MD

Slideshows

Here's the latest multidisciplinary MS research published online first in the International Journal of MS Care.

IJMSC Online First: March 2023

Director, Comprehensive Epilepsy Center, NYU Langone Health

The director of the Comprehensive Epilepsy Center at NYU Langone discussed the importance of healthy eating habits and whether all individuals with epilepsy should consider dieting early in their life. [WATCH TIME: 4 minutes]

Importance of Establishing Healthy Eating Habits in Epilepsy: Orrin Devinsky, MD

The vascular neurologist at Cleveland Clinic provided an overview of a study that assessed the extent HbA1c impacts the relationship between mechanical thrombectomy and poor outcomes. [WATCH TIME: 3 minutes]

Effect of HbA1c Elevation, Glycemic Control Following Mechanical Thrombectomy: David Baker, DO

NeurologyLive is your direct connection to the latest neurology news and interviews with expert neurologists in multimedia formats.

About Us

Advisory Board

Editorial

Contact Us

Advertise

Contact MJH LS

Do Not Sell My Information

Terms and Conditions

Privacy

NeurologyLive – Clinical Neurology News and Neurology Expert Insights

Facebook

Twitter

LinkedIN

Spotlight

MDA 2023

NMOSD

Narcolepsy

Parkinson Disease

Clinical Focus

Dementia/Alzheimer

Headache/Migraine

Video Series

1rem

View

Because dark chocolate is relatively inexpensive-and many people like its taste-it could be a pragmatic adjunct to treatment in MS.

Clinical

EMD-22-NRD0193 - /clinical/multiple-sclerosis

Dark Chocolate Fights Fatigue in Multiple Sclerosis

Dark Chocolate Fights Fatigue in Multiple Sclerosis

NeurologyLive® Friday 5 — March 24, 2023

Episode 83: The ARISE Study and Using DMTs in RIS

NeurologyLive® Friday 5 — March 17, 2023

Episode 76: ECTRIMS 2022 and the Latest in MS Advances

Using MRIs to Detect Early Signs of Viral Infections in Multiple Sclerosis

Applying Artificial Intelligence to Monitor Multiple Sclerosis Disease Progression

NeurologyLive® Friday 5 — March 24, 2023

Episode 83: The ARISE Study and Using DMTs in RIS

NeurologyLive® Friday 5 — March 17, 2023

Episode 76: ECTRIMS 2022 and the Latest in MS Advances

Using MRIs to Detect Early Signs of Viral Infections in Multiple Sclerosis

Applying Artificial Intelligence to Monitor Multiple Sclerosis Disease Progression

NeurologyLive® Friday 5 — March 24, 2023

Episode 83: The ARISE Study and Using DMTs in RIS

NeurologyLive® Friday 5 — March 17, 2023

Episode 76: ECTRIMS 2022 and the Latest in MS Advances

Using MRIs to Detect Early Signs of Viral Infections in Multiple Sclerosis

Applying Artificial Intelligence to Monitor Multiple Sclerosis Disease Progression